Paradox of disproportionate atrial functional mitral regurgitation and survival after transcatheter edge-to-edge repair

被引:3
作者
Doldi, Philipp M. [1 ,2 ]
Stolz, Lukas [1 ,2 ]
Kassar, Mohammad [3 ]
Kalbacher, Daniel [4 ]
Petronio, Anna Sonia [5 ]
Butter, Christian [6 ]
von Bardeleben, Ralph Stephan [7 ]
Iliadis, Christos [8 ]
Grayburn, Paul [9 ]
Hausleiter, Joerg [1 ,2 ,10 ]
机构
[1] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany
[2] Partner Site German Ctr Cardiovasc Dis DZHK, Munich Heart Alliance, Munich, Germany
[3] Bern Univ Hosp, Univ Klin Kardiol, Inselspital Bern, Bern, Switzerland
[4] Univ Herz & Gefasszentrum Hamburg, Klin Kardiol, Hamburg, Germany
[5] Univ Pisa, Cardiothorac & Vasc Dept, Cardiac Catheterizat Lab, Pisa, Italy
[6] Med Hsch Brandenburg Theodor Fontane, Herzzentrum Brandenburg, Bernau, Germany
[7] Johannes Gutenberg Univ Mainz, Zentrum Kardiol, Mainz, Germany
[8] Univ Cologne, Dept Internal Med 3, Heart Ctr, Cologne, Germany
[9] Baylor Univ, Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX USA
[10] Med Klin & Poliklin I, Marchioninistr15, D-81377 Munich, Germany
来源
ESC HEART FAILURE | 2024年 / 11卷 / 04期
关键词
atrial functional MR; MR proportionality; transcatheter mitral valve repair; valvular heart disease;
D O I
10.1002/ehf2.14789
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThis study aims to assess the applicability of the mitral regurgitation (MR) proportionality concept in patients with atrial functional mitral regurgitation (aFMR) treated with transcatheter edge-to-edge repair (M-TEER). We hypothesized that patients with disproportionate MR (higher MR relative to left ventricular size) would exhibit different outcomes compared to those with proportionate MR, despite undergoing M-TEER. Methods and results We retrospectively analysed 98 patients with aFMR from the EuroSMR registry who underwent M-TEER between 2008 and 2019. Patients met criteria for aFMR (normal indexed left ventricular end-diastolic volume [LVEDV], preserved left ventricular ejection fraction [LVEF] >= 50% without regional wall motion abnormalities, and structurally normal mitral valves). We excluded patients with missing effective regurgitant orifice area (EROA) or LVEDV data. The primary endpoint was 2-year mortality, with an EROA/LVEDV ratio employed to differentiate disproportionate from proportionate MR. Procedural success and baseline characteristics were analysed, and multivariate Cox proportional hazards models were used to identify mortality predictors. The mean patient age was 79 +/- 7.3 years, with 68.8% female, and 79% had a history of atrial fibrillation. The mean EROA was 0.27 +/- 0.14 cm(2), and LVEDV was 95.6 +/- 33.7 mL. Disproportionate MR was identified with an EROA/LVEDV ratio >0.339 cm(2)/100 mL. While procedural success was similar in both groups, disproportionate MR was associated with a numerically higher estimate of systolic pulmonary artery pressures (sPAP) and rates of NYHA >= III and TR >= 3+. Disproportionate MR had a significant association with increased 2-year mortality (P < 0.001). The EROA/LVEDV ratio and tricuspid annular plane systolic excursion (TAPSE) were independent predictors of 2-year mortality (EROA/LVEDV: HR: 1.35, P = 0.010; TAPSE: HR: 0.85, P = 0.020). Conclusions This analysis introduces the MR proportionality concept in aFMR patients and its potential prognostic value. Paradoxically, disproportionate MR in aFMR was linked to a 1.35-fold increase in 2-year mortality post-M-TEER, emphasizing the importance of accurate preprocedural FMR characterization. Our findings in patients with disproportionate MR indicate that a high degree of aFMR with high regurgitant volumes may lead to aggravated symptoms, which is a known contributor to increased mortality following M-TEER. These results underline the need for further research into the pathophysiology of aFMR to inform potential preventative and therapeutic strategies, ensuring optimal patient outcomes.
引用
收藏
页码:2447 / 2450
页数:4
相关论文
共 4 条
  • [1] Bartko PE, 2020, JACC-CARDIOVASC IMAG, V13, P1458, DOI 10.1016/j.jcmg.2019.11.026
  • [2] Transcatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation
    Doldi, Philipp
    Stolz, Lukas
    Orban, Mathias
    Karam, Nicole
    Praz, Fabien
    Kalbacher, Daniel
    Lubos, Edith
    Braun, Daniel
    Adamo, Marianna
    Giannini, Cristina
    Melica, Bruno
    Naebauer, Michael
    Higuchi, Satoshi
    Wild, Mirjam
    Neuss, Michael
    Butter, Christian
    Kassar, Mohammad
    Petrescu, Aniela
    Pfister, Roman
    Iliadis, Christos
    Unterhuber, Matthias
    Thiele, Holger
    Baldus, Stephan
    von Bardeleben, Ralph Stephan
    Schofer, Niklas
    Hagl, Christian
    Petronio, Anna Sonia
    Massberg, Steffen
    Windecker, Stephan
    Lurz, Philipp
    Metra, Marco
    Hausleiter, Joerg
    [J]. JACC-CARDIOVASCULAR IMAGING, 2022, 15 (11) : 1843 - 1851
  • [3] Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation
    Farhan, Serdar
    Silbiger, Jeffrey J.
    Halperin, Jonathan L.
    Zhang, Lily
    Dukkipati, Srinivas R.
    Vogel, Birgit
    Kini, Annapoorna
    Sharma, Samin
    Lerakis, Stamatios
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (24) : 2314 - 2330
  • [4] Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials
    Grayburn, Paul A.
    Sannino, Anna
    Packer, Milton
    [J]. JACC-CARDIOVASCULAR IMAGING, 2019, 12 (02) : 353 - 362